Sang-Kon Oh

Title: **Innovator Profile: Sang-Kon Oh**

Introduction

Sang-Kon Oh is a notable inventor based in Baltimore, MD, recognized for his contributions to the field of vaccine development. His innovative work focuses on enhancing the immunogenicity of vaccines, which is a critical area in immunology and public health.

Latest Patents

Sang-Kon Oh holds one patent titled "Recombinant vaccine viruses expressing IL-15 and methods using the same." This invention aims to improve vaccine efficacy by utilizing compositions that augment the immunogenicity of a vaccine. Specifically, the adjuvant can be administered in either sequential or concurrent combination with a vaccine antigen. One of its preferred forms includes a recombinant poxvirus vector, such as a vaccinia virus vector, which encodes a nucleic acid sequence for IL-15.

Career Highlights

Sang-Kon Oh's career is marked by his association with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. This role underscores his commitment to advancing public health through innovative scientific research.

Collaborations

Throughout his career, Sang-Kon Oh has collaborated with esteemed colleagues, including Liyanage Parakrama Perera and Thomas Alexander Waldmann. Their joint efforts enhance the quality and reach of their research in vaccine development.

Conclusion

Sang-Kon Oh's patent and ongoing research reflect a profound dedication to improving vaccine technology and public health outcomes. His innovative approach in developing recombinant vaccine viruses illustrates the vital role that inventors play in the advancement of medical science.